| The development and validation of tau PET tracers: current status and future directions |
23 |
| The new opportunities for high time resolution clinical TOF PET |
23 |
| F-18-labelling innovations and their potential for clinical application |
12 |
| Comprehensive meta-analysis on [F-18] FDG PET/CT and radiolabelled leukocyte SPECT-SPECT/CT imaging in infectious endocarditis and cardiovascular implantable electronic device infections |
8 |
| Advances in clinical molecular imaging instrumentation |
8 |
| SPECT vs. PET in cardiac innervation imaging: clash of the titans |
7 |
| An update on radiotracer development for molecular imaging of bacterial infections |
7 |
| PSMA diagnostics and treatments of prostate cancer become mature |
6 |
| FDG PET radiomics: a review of the methodological aspects |
6 |
| A glance at imaging bladder cancer |
5 |
| Fluorescent imaging of bacterial infections and recent advances made with multimodal radiopharmaceuticals |
5 |
| Combined Ga-68-DOTA-peptides and F-18-FDG PET in the diagnostic work-up of neuroendocrine neoplasms (NEN) |
4 |
| Thyroid cancer radiotheragnostics: the case for activity adjusted I-131 therapy |
4 |
| Radiolabelled nanoparticles for cancer diagnosis |
3 |
| Radiopharmacology and molecular imaging of PD-L1 expression in cancer |
3 |
| Recent developments of prostate-specific membrane antigen (PSMA)-specific radiopharmaceuticals for precise imaging and therapy of prostate cancer: an overview |
3 |
| Peptide receptor radionuclide therapy for neuroendocrine tumours |
2 |
| The role of PET/CT in the evaluation of patients with urothelial cancer: a systematic review and meta-analysis |
2 |
| Ga-68-DOTA-peptides PET/MRI in pancreatico-duodenal neuroendocrine tumours: a flash pictorial essay on assets and lacks |
2 |
| PET/MRI for neuroendocrine tumors: a match made in heaven or just another hype? |
2 |
| Hodgkin lymphoma and imaging in the era of anti-PD-1/PD-L1 therapy |
2 |
| Role of myocardial I-123-mIBG innervation imaging in the diagnosis of neurodegenerative diseases |
2 |
| Tau PET imaging evidence in patients with cognitive impairment: preparing for clinical use |
2 |
| Evidence-based indications for the planning of PET or PET/CT capacities are needed |
2 |
| The value of yttrium-90 PET/CT after hepatic radioembolization: a pictorial essay |
2 |
| Value of FDG-PET/CT for treatment response in tuberculosis: a systematic review and meta-analysis |
2 |
| FDG-PET/CT for diagnosis of cyst infection in autosomal dominant polycystic kidney disease |
2 |
| HTA in nuclear medicine: [Ga-68]PSMA PET/CT for patients with prostate cancer |
2 |
| Perspectives of quantitative assessment of myocardial blood flow |
2 |
| F-18-FDG-PET and MRI in autoimmune encephalitis: a systematic review of brain findings |
2 |
| Pictorial essay: normal variants, lesions, and pitfalls in Ga-68-PSMA PET imaging of prostate cancer |
2 |
| FDG-PET/CT in venous thromboembolism |
2 |
| Lu-177-PSMA treatment for metastatic prostate cancer: case examples of major responses |
1 |
| PET/CT for the diagnostic assessment of patients with testicular cancer |
1 |
| PET/CT for the diagnostic assessment of patients with renal cancer |
1 |
| Role of thyroglobulin in the management of patients with differentiated thyroid cancer |
1 |
| The role of functional imaging in lung cancer |
1 |
| Detection rate of radiolabelled choline PET or PET/CT in hepatocellular carcinoma: an updated systematic review and meta-analysis |
1 |
| PET biomarkers and probes for treatment response assessment in glioblastoma: a work in progress |
1 |
| PET myocardial perfusion quantification: anatomy of a spreading functional technique |
1 |
| Cardiac amyloidosis |
1 |
| Towards consensus in acquisition and image analysis of PET and SPECT in the assessment of cardiac sympathetic innervation: a mini-review |
1 |
| Imaging gastrin-releasing peptide receptors (GRPRs) in prostate cancer |
1 |
| Lower limb lymphoscintigraphy patterns among patients with lower limb lymphedema: a pictorial essay |
1 |
| Hybrid cardiac PET/MR: the value of multiparametric assessment in cardiac sarcoidosis |
1 |
| A look ahead: future directions of SSR-directed imaging and therapy in meningioma |
1 |
| Sentinel lymph node biopsy in oral- oropharyngeal squamous cell carcinoma: standards, new technical procedures, and clinical advances |
1 |
| Multimodal therapy of advanced differentiated thyroid cancer, with emphasis on the role of radioiodine |
1 |
| Diagnostic performance of FDG PET in large vessel vasculitis |
0 |
| Investigations of possible links between Alzheimer's disease and type 2 diabetes mellitus by positron emission tomography: a systematic review |
0 |
